Difficulty: Medium
Average Score: 78%
Practice
A 48-year-old woman has been treated for type 2 diabetes for 6 years with metformin 2000 mg daily, and glyburide 10 mg daily. She is modestly compliant with her diet, medications, and exercise. She is 69 in. tall and weighs 278 lb. Her most recent HbA1C is 8.2% which is relatively unchanged over the past 18 months. If weight loss is a therapeutic priority for this patient, which of the following would represent a logical next step?
Correct answer
D
Rationale
Exenatide promotes weight loss and improves glycemic control in patients with type 2 diabetes.